Gesynta Pharma Raises SEK 304 Million to Advance Novel Endometriosis Treatment

AnaCardio raises USD 19 million to advance first-in-class drug candidate AC01 for heart failure

Calliditas Therapeutics: A Case Study of Strategic Investment and Successful Exit by Industrifonden

Jonathan Ilicki, Principal at Industrifonden, Selected for Obama Leaders Europe Program

Cellevate closes second seed round, raising 3.2 MEUR to enter into global commercialization

Industrifonden Celebrates Successful Exit as Calliditas Therapeutics is Acquired by Asahi Kasei

SaltX Technology appoints Lina Jorheden as acting CEO and strengthens its financial position with additional funding

Industrifonden leads SEK 15 million investment round in BrainZell – pioneering the future of medicine for neurological diseases

SaltX secures SEK 38 million and enters partnership with ABB